Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2014 16:45 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Third Quarter 2014 Results

TORONTO, Oct. 15, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
September 30, 2014 17:25 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Resignation of Chief Financial Officer

TORONTO, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
August 28, 2014 16:43 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology

TORONTO, Aug. 28, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
July 07, 2014 18:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Second Quarter 2014 Results

TORONTO, July 7, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
May 20, 2014 17:45 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement

TORONTO, May 20, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
April 14, 2014 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces First Quarter 2014 Results

TORONTO, April 14, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 19, 2014 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014

TORONTO, March 19, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 04, 2014 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at Two Upcoming Investor Conferences

TORONTO, March 4, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
February 18, 2014 07:05 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces 2013 Year End Results

TORONTO, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
February 03, 2014 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc.

- First Profit-Share Payment on 15 and 30 mg Generic Focalin XR® Sales TORONTO, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a...